Management of chronic pain in the elderly: focus on transdermal buprenorphine

References

• AbrahmJ2000Advances in pain management for older adult patientsClin Geriatr Med1626931110783429
   PubMed Web of Science ®Google Scholar
• AngstMKoppertWPahlI2003Short-term infusion of the mu-opioid agonist remifentanil in humans causes hyperalgesia during withdrawalPain106495714581110
   PubMed Web of Science ®Google Scholar
• BalintG2002Buprenorphine treatment of patients with non-malignant musculoskeletal diseasesClin Rheumatol21Suppl 1S17811954898
   PubMed Web of Science ®Google Scholar
• BalázsERuszwurmASzékelyM2008[Old age and kidneys]Orv Hetil1497899418426760
   PubMedGoogle Scholar
• BenedettiFVighettiSAmanzioM1998Dose-response relationship of opioids in nociceptive and neuropathic postoperative painPain74205119520235
   PubMed Web of Science ®Google Scholar
• Bloms-FunkePGillenCSchuettlerA2000Agonistic effects of the opioid buprenorphine on the nociceptin/OFQ receptorPeptides211141610998549
   PubMed Web of Science ®Google Scholar
• BohmeK2002Buprenorphine in a transdermal therapeutic system–a new optionClin Rheumatol21Suppl 1S13611954897
   PubMed Web of Science ®Google Scholar
• BookSMyrickHMalcolmR2007Buprenorphine for postoperative pain following general surgery in a buprenorphine-maintained patientAm J Psychiatry16497917541066
   PubMed Web of Science ®Google Scholar
• BowsherD1999The lifetime occurrence of Herpes zoster and prevalence of post-herpetic neuralgia:A retrospective survey in an elderly populationEur J Pain33354210700361
   PubMed Web of Science ®Google Scholar
• BrewsterDHumphreyMJMcLeavyMA1981Biliary excretion, metabolism and enterohepatic circulation of buprenorphineXenobiotica11189967293215
   PubMed Web of Science ®Google Scholar
• BuddK2003Buprenorphine and the transdermal system:the ideal match in pain managementInt J Clin PractSuppl914 discussion 23–412587934
   PubMed Web of Science ®Google Scholar
• BuddKCollettBJ2003Old dog–new ma.trixBr J Anaesth90722412765884
   PubMed Web of Science ®Google Scholar
• CastenRJParmeleePAKlebanMH1995The relationships among anxiety, depression, and pain in a geriatric institutionalized samplePain6127167659437
   PubMed Web of Science ®Google Scholar
• ChrubasikJMartinEChrubasikS1994Epidural buprenorphine. How safe is “safe”Acta Anaesthesiol Scand3852567941951
   PubMed Web of Science ®Google Scholar
• ClarotFProustBVazE2003Tramadol-benzodiazepines and buprenorphine-benzodiazepines:two potentially fatal cocktails?J Clin Forensic Med10125615275034
   PubMedGoogle Scholar
• CleelandCSGoninRHatfieldAK1994Pain and its treatment in outpatients with metastatic cancerN Engl J Med33059267508092
   PubMed Web of Science ®Google Scholar
• ConeEJGorodetzkyCWYousefnejadD1984The metabolism and excretion of buprenorphine in humansDrug Metab Dispos12577816149907
   PubMed Web of Science ®Google Scholar
• CrookJRideoutEBrowneG1984The prevalence of pain complaints in a general populationPain182993146728496
   PubMed Web of Science ®Google Scholar
• CélèrierERivatCJunY2000Long-lasting hyperalgesia induced by fentanyl in rats:preventive effect of ketamineAnesthesiology924657210691234
   PubMed Web of Science ®Google Scholar
• D’eliaMPatenaudeJHamelinC2003No detrimental effect from chronic exposure to buprenorphine on corticosteroid-binding globulin and corticosensitive immune parametersClin Immunol1091798714597216
   PubMed Web of Science ®Google Scholar
• DahanAYassenABijlH2005Comparison of the respiratory effects of intravenous buprenorphine and fentanyl in humans and ratsBr J Anaesth948253415833777
   PubMed Web of Science ®Google Scholar
• DahanAYassenARombergR2006Buprenorphine induces ceiling in respiratory depression but not in analgesiaBr J Anaesth966273216547090
   PubMed Web of Science ®Google Scholar
• DavisMSrivastavaM2003Demographics, assessment and management of pain in the elderlyDrugs Aging20235712513114
   PubMed Web of Science ®Google Scholar
• DowningJWGoodwinNMHicksJ1979The respiratory depressive effects of intravenous buprenorphine in patients in an intensive care unitS Afr Med J5510237483080
   PubMed Web of Science ®Google Scholar
• EbertBAndersenSKrogsgaard-LarsenP1995Ketobemidone, methadone and pethidine are non-competitive N-methyl-D-aspartate NMDA. antagonists in the rat cortex and spinal cordNeurosci Lett18716587624018
   PubMed Web of Science ®Google Scholar
• EvansHEasthopeS2003Transdermal buprenorphineDrugs631999010 discussion 2011–212962515
   PubMed Web of Science ®Google Scholar
• FilitzJGriessingerNSittlR2006Effects of intermittent hemodialysis on buprenorphine and norbuprenorphine plasma concentrations in chronic pain patients treated with transdermal buprenorphineEur J Pain10743816426877
   PubMed Web of Science ®Google Scholar
• FoleyKM2003Opioids and chronic neuropathic painN Engl J Med34812798112660393
   PubMed Web of Science ®Google Scholar
• FreyeEAnderson-HillemacherARitzdorfI2007Opioid rotation from high-dose morphine to transdermal buprenorphine Transtec. in chronic pain patientsPain Pract7123917559481
   PubMedGoogle Scholar
• GaglieseLMelzackR1997Chronic pain in elderly peoplePain703149106804
   PubMed Web of Science ®Google Scholar
• GalTJ1989Naloxone reversal of buprenorphine-induced respiratory depressionClin Pharmacol Ther4566712491980
   PubMed Web of Science ®Google Scholar
• GandySPayneR1986Back pain in the elderly:updated diagnosis and managementGeriatrics41596267742946627
   PubMed Web of Science ®Google Scholar
• Gomez-FloresRWeberR2000Differential effects of buprenorphine and morphine on immune and neuroendocrine functions following acute administration in the rat mesencephalon periaqueductal grayImmunopharmacology481455610936512
   PubMed Web of Science ®Google Scholar
• GraziottiPJGouckeCR1997The use of oral opioids in patients with chronic non-cancer pain. Management strategiesMed J Aust1673049236757
   PubMed Web of Science ®Google Scholar
• GreenwaldMJohansonCMoodyD2003Effects of buprenorphine maintenance dose on mu-opioid receptor availability, plasma concentrations, and antagonist blockade in heroin-dependent volunteersNeuropsychopharmacology282000912902992
   PubMed Web of Science ®Google Scholar
• GriessingerNSittlRLikarR2005Transdermal buprenorphine in clinical practice—a post-marketing surveillance study in 13,179 patientsCurr Med Res Opin2111475616083522
   PubMed Web of Science ®Google Scholar
• GrondSRadbruchLLehmannKA2000Clinical pharmacokinetics of transdermal opioids:focus on transdermal fentanylClin Pharmacokinet38598910668859
   PubMed Web of Science ®Google Scholar
• HandCSearJUppingtonJ1990Buprenorphine disposition in patients with renal impairment:single and continuous dosing, with special reference to metabolitesBr J Anaesth64276822328175
   PubMed Web of Science ®Google Scholar
• HeelRCBrogdenRNSpeightTM1979Buprenorphine:a review of its pharmacological properties and therapeutic efficacyDrugs1781110378645
   PubMed Web of Science ®Google Scholar
• HelmeRDKatzBGibsonS1989Can psychometric tools be used to analyse pain in a geriatric population?Clin Exp Neurol2611372642122
   PubMedGoogle Scholar
• IbrahimRWilsonJThorsbY2000Effect of buprenorphine on CYP3A activity in rat and human liver microsomesLife Sci661293810755464
   PubMed Web of Science ®Google Scholar
• IribarneCPicartDDréanoY1998In vitro interactions between fluoxetine or fluvoxamine and methadone or buprenorphineFundam Clin Pharmacol1219499565774
   PubMed Web of Science ®Google Scholar
• JasinskiDRPevnickJSGriffithJD1978Human pharmacology and abuse potential of the analgesic buprenorphine:a potential agent for treating narcotic addictionArch Gen Psychiatry3550116215096
   PubMed Web of Science ®Google Scholar
• JensenMFosterDUptonR2007Population pharmacokinetics of buprenorphine following a two-stage intravenous infusion in healthy volunteersEur J Clin Pharmacol631153917874319
   PubMed Web of Science ®Google Scholar
• JiangRRobertsMSPrankerdRJ1997Percutaneous absorption of sunscreen agents from liquid paraffin:self-association of octyl salicylate and effects on skin fluxJ Pharm Sci8679169232518
   PubMed Web of Science ®Google Scholar
• JohnsonREFudalaPJPayneR2005Buprenorphine:considerations for pain managementJ Pain Symptom Manage2929732615781180
   PubMed Web of Science ®Google Scholar
• KintzP2002A new series of 13 buprenorphine-related deathsClin Biochem35513612493578
   PubMed Web of Science ®Google Scholar
• KiselySTweddleDPughEW1992Dementia presenting with sore eyesBr J Psychiatry16112011638310
   PubMed Web of Science ®Google Scholar
• KnapeJ1986Early respiratory depression resistant to naloxone following epidural buprenorphineAnesthesiology6438243954137
   PubMed Web of Science ®Google Scholar
• KoppertWIhmsenHKörberN2005Different profiles of buprenorphine-induced analgesia and antihyperalgesia in a human pain modelPain118152216154698
   PubMed Web of Science ®Google Scholar
• KouyaPFHaoJXXuXJ2002Buprenorphine alleviates neuropathic pain-like behaviors in rats after spinal cord and peripheral nerve injuryEur J Pharmacol450495312176108
   PubMed Web of Science ®Google Scholar
• LaiSHTeoCE2006Buprenorphine-associated deaths in SingaporeAnn Acad Med Singapore355081116902730
   PubMed Web of Science ®Google Scholar
• LikarRGriessingerNSadjakA2003[Transdermal buprenorphine for treatment of chronic tumor and non-tumor pain]Wien Med Wochenschr1533172212924108
   PubMedGoogle Scholar
• LikarRKayserHSittlR2006Long-term management of chronic pain with transdermal buprenorphine:a multicenter, open-label, follow-up study in patients from three short-term clinical trialsClin Ther289435216860176
   PubMed Web of Science ®Google Scholar
• LikarRSittlR2005Transdermal buprenorphine for treating nociceptive and neuropathic pain:four case studiesAnesth Analg100781515728068
   PubMed Web of Science ®Google Scholar
• MaoJPriceDDMayerDJ1995Experimental mononeuropathy reduces the antinociceptive effects of morphine:implications for common intra-cellular mechanisms involved in morphine tolerance and neuropathic painPain61353647478678
   PubMed Web of Science ®Google Scholar
• McQuayHJ2002Neuropathic pain:evidence mattersEur J Pain6Suppl A11811888235
   PubMed Web of Science ®Google Scholar
• MurielCFaildeIMicoJA2005Effectiveness and tolerability of the buprenorphine transdermal system in patients with moderate to severe chronic pain:a multicenter, open-label, uncontrolled, prospective, observational clinical studyClin Ther274516215922818
   PubMed Web of Science ®Google Scholar
• NegusSSMelloNKLinsenmayerDC2002Kappa opioid antagonist effects of the novel kappa antagonist 5′-guanidinonaltrindole GNTI. in an assay of schedule-controlled behavior in rhesus monkeysPsychopharmacology Berl163412912373442
   PubMed Web of Science ®Google Scholar
• OhtaniMKotakiHNishitatenoK1997Kinetics of respiratory depression in rats induced by buprenorphine and its metabolite, norbuprenorphineJ Pharmacol Exp Ther281428339103526
   PubMed Web of Science ®Google Scholar
• OmoteKOhmoriHKawamataM1995Intrathecal buprenorphine in the treatment of phantom limb painAnesth Analg80103027726400
   PubMed Web of Science ®Google Scholar
• OrwinJOrwinJPriceM1976A double blind comparison of buprenorphine and morphine in conscious subjects following administration by the intramuscular routeActa Anaesthesiol Belg27171811032070
   PubMed Web of Science ®Google Scholar
• PaceMCPassavantiMBGrellaE2007Buprenorphine in long-term control of chronic pain in cancer patientsFront Biosci121291917127381
   PubMed Web of Science ®Google Scholar
• ParikhA2007Principles of geriatric pharmacologyJ Indian Med Assoc1052828417915800
   PubMedGoogle Scholar
• PavelkaKLe LoetXBjorneboeO2004Benefits of transdermal fentanyl in patients with rheumatoid arthritis or with osteoarthritis of the knee or hip:an open-label study to assess pain controlCurr Med Res Opin2019677715701214
   PubMed Web of Science ®Google Scholar
• PepeGJWaddellBJStahlSJ1988The regulation of transplacental cortisol-cortisone metabolism by estrogen in pregnant baboonsEndocrinology12278833335215
   PubMed Web of Science ®Google Scholar
• PrianoLGascoMRMauroA2006Transdermal treatment options for neurological disorders:impact on the elderlyDrugs Aging233577516823990
   PubMed Web of Science ®Google Scholar
• ReynaudMTracquiAPetitG1998Six deaths linked to misuse of buprenorphine-benzodiazepine combinationsAm J Psychiatry15544899501765
   PubMed Web of Science ®Google Scholar
• RowbothamMCTwillingLDaviesPS2003Oral opioid therapy for chronic peripheral and central neuropathic painN Engl J Med34812233212660386
   PubMed Web of Science ®Google Scholar
• ShahFHalbeAPanchalI2003Improvement in postoperative pain relief by the addition of midazolam to an intrathecal injection of buprenorphine and bupivacaineEur J Anaesthesiol209041014649343
   PubMed Web of Science ®Google Scholar
• SimonnetG2005Opioids: from analgesia to anti-hyperalgesia?Pain1188916202525
   PubMed Web of Science ®Google Scholar
• SimonnetGRivatC2003Opioid-induced hyperalgesia: abnormal or normal pain?Neuroreport141712544821
   PubMed Web of Science ®Google Scholar
• SimpsonKH2002Individual choice of opioids and formulations:strategies to achieve the optimum for the patientClin Rheumatol21Suppl 1S5811954900
   PubMed Web of Science ®Google Scholar
• SittlR2006Transdermal buprenorphine in cancer pain and palliative carePalliat Med20Suppl 1s253016764218
   PubMed Web of Science ®Google Scholar
• SittlRGriessingerNLikarR2003Analgesic efficacy and tolerability of transdermal buprenorphine in patients with inadequately controlled chronic pain related to cancer and other disorders: a multicenter, randomized, double-blind, placebo-controlled trialClin Ther251506812637117
   PubMed Web of Science ®Google Scholar
• SittlRNuijtenMNautrupB2005Changes in the prescribed daily doses of transdermal fentanyl and transdermal buprenorphine during treatment of patients with cancer and noncancer pain in Germany: results of a retrospective cohort studyClin Ther2710223116154481
   PubMed Web of Science ®Google Scholar
• SittlRNuijtenMNautrupBP2006Patterns of dosage changes with transdermal buprenorphine and transdermal fentanyl for the treatment of noncancer and cancer pain: a retrospective data analysis in GermanyClin Ther2811445416982291
   PubMed Web of Science ®Google Scholar
• SorgeJSittlR2004Transdermal buprenorphine in the treatment of chronic pain: results of a phase III, multicenter, randomized, double-blind, placebo-controlled studyClin Ther2618082015639693
   PubMed Web of Science ®Google Scholar
• SummerfieldRAllenMMooreR1985Buprenorphine in end stage renal failureAnaesthesia409144051160
   PubMed Web of Science ®Google Scholar
• ThompsonJBowerSLiddleA1998Perioperative pharmacokinetics of transdermal fentanyl in elderly and young adult patientsBr J Anaesth8115249813514
   PubMed Web of Science ®Google Scholar
• UmeharaKShimokawaYMiyamotoG2002Inhibition of human drug metabolizing cytochrome P450 by buprenorphineBiol Pharm Bull25682512033517
   PubMed Web of Science ®Google Scholar
• VadiveluNHinesRL2007Buprenorphine: a unique opioid with broad clinical applicationsJ Opioid Manag3495817367094
   PubMedGoogle Scholar
• VentafriddaVDe ConnoFGuariseG1983Chronic analgesic study on buprenorphine action in cancer pain. Comparison with pentazocineArzneimittelforschung33587906683540
   PubMed Web of Science ®Google Scholar
• WalshSLPrestonKLBigelowGE1995Acute administration of buprenorphine in humans:partial agonist and blockade effectsJ Pharmacol Exp Ther274361727542336
   PubMed Web of Science ®Google Scholar
• WalshSLPrestonKLStitzerML1994Clinical pharmacology of buprenorphine:ceiling effects at high dosesClin Pharmacol Ther55569808181201
   PubMed Web of Science ®Google Scholar
• WooJHoSCLauJ1994Musculoskeletal complaints and associated consequences in elderly Chinese aged 70 years and overJ Rheumatol211927317837161
   PubMed Web of Science ®Google Scholar
• YassenAOlofsenEDahanA2005Pharmacokinetic-pharmacodynamic modeling of the antinociceptive effect of buprenorphine and fentanyl in rats: role of receptor equilibration kineticsJ Pharmacol Exp Ther31311364915701707
   PubMed Web of Science ®Google Scholar
• ZakiPAKeithDEJrBrineGA2000Ligand-induced changes in surface mu-opioid receptor number:relationship to G protein activation?J Pharmacol Exp Ther29211273410688632
   PubMed Web of Science ®Google Scholar
• ZhangYDuLNWuGC1998Modulation of intrathecal morphine-induced immunosuppression by microinjection of naloxone into periaqueductal grayZhongguo Yao Li Xue Bao195192210437136
   PubMed Web of Science ®Google Scholar